Nitric oxide regulation of penile erection: biology and therapeutic implications.
Burnett
Arthur L
AL
Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland 21287, USA. aburnett@jhmi.edu
D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000818:Animals; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D004789:Enzyme Activation / Q000502:physiology; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006162:Guanylate Cyclase / Q000378:metabolism; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000502:physiology*; D010410:Penile Erection / Q000502:physiology*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism
D010726:Phosphodiesterase Inhibitors; D009569:Nitric Oxide; D010727:Phosphoric Diester Hydrolases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human; D006162:Guanylate Cyclase